|
This report represents 1 of 7 (b)(6) alere determine hiv 1/2 ag/ab combo patient results (fingerstick whole blood) reported from a customer to an alere representative.(b)(6 were confirmed (b)(6) by a 4th generation hiv test.There is insufficient information to determine if a malfunction occurred.The patient(s) gender, pregnancy status, treatment and patient outcome were unknown.The date(s) of occurrence are unknown.At the time of the event there was no indication of a product malfunction based on the information provided and assessed by alere (b)(4), inc.; however, this mdr is a retrospective filing in response to an observation from an fda inspection conducted february 26th to march 2nd, 2018 at alere (b)(4).
|